NICE technology appraisals
This article was originally published in The Gray Sheet
Coronary artery stents, implantable cardioverter defibrillators, and hip prostheses will be evaluated this fall by the National Institute For Clinical Excellence, a technology appraisal program for the National Health Service in the U.K. (1"The Gray Sheet" March 22, p. 12). Manufacturers of the selected products are expected to submit existing data on clinical and cost effectiveness, the group explains Aug. 6. NICE will issue a guidance on each manufacturer's technology, indicating "whether, and under what circumstances, the technology should be routinely used in the NHS" and "whether its use should be restricted to certain categories of patients." Other areas to be examined include cervical screening, inhaler systems, hearing aids, laparoscopic surgery, and wound care
You may also be interested in...
Britain's National Institute of Clinical Excellence (NICE) plans to conduct on an annual basis clinical and cost-effectiveness evaluations of between 30 and 50 new and existing medical technologies, Edward Hutt, division director Quintiles Medical Technology Consultants, said March 14.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.